# FDA Inspection 1266325 - Samuel M. Alexander, M.D. - March 27, 2025

Source: https://www.keypedia.com/records/fda_inspections/samuel-m-alexander-md/75b51d53-4485-4908-bd8b-66e8a040e2f1
Source feed: FDA_Inspections

> FDA Inspection 1266325 for Samuel M. Alexander, M.D. on March 27, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1266325
- Company Name: Samuel M. Alexander, M.D.
- Inspection Date: 2025-03-27
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1266325 - 2025-03-27](https://www.keypedia.com/records/fda_inspections/samuel-m-alexander-md/eaade0f6-0d5e-48f4-8e4f-0001312e686f)

Company: https://www.keypedia.com/companies/samuel-m-alexander-md/75893b2b-33fa-4724-8358-50e3ddc974a3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c